NO20016427D0 - Blandinger og fremgangsmåter for behandling av diagnose av lungekreft - Google Patents

Blandinger og fremgangsmåter for behandling av diagnose av lungekreft

Info

Publication number
NO20016427D0
NO20016427D0 NO20016427A NO20016427A NO20016427D0 NO 20016427 D0 NO20016427 D0 NO 20016427D0 NO 20016427 A NO20016427 A NO 20016427A NO 20016427 A NO20016427 A NO 20016427A NO 20016427 D0 NO20016427 D0 NO 20016427D0
Authority
NO
Norway
Prior art keywords
diagnosis
compositions
treatment
methods
lung cancer
Prior art date
Application number
NO20016427A
Other languages
English (en)
Other versions
NO20016427L (no
Inventor
Tongtong Wang
Chaitanya S Bangur
Michael J Lodes
Gary R Fanger
Thomas S Vedvick
Darrick Carter
Marc W Retter
Jane Mannison
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/476,300 external-priority patent/US20030125245A1/en
Priority claimed from US09/589,184 external-priority patent/US6686447B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20016427D0 publication Critical patent/NO20016427D0/no
Publication of NO20016427L publication Critical patent/NO20016427L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016427A 1999-06-30 2001-12-28 Blandinger og fremgangsmåter for behandling av diagnose av lungekreft NO20016427L (no)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US34649299A 1999-06-30 1999-06-30
US41935699A 1999-10-15 1999-10-15
US46686799A 1999-12-17 1999-12-17
US09/476,300 US20030125245A1 (en) 1999-06-30 1999-12-30 Compositions and methods for therapy and diagnosis of lung cancer
US09/519,642 US6933363B1 (en) 1999-06-30 2000-03-06 Compositions and methods for therapy and diagnosis of lung cancer
US53307700A 2000-03-22 2000-03-22
US54625900A 2000-04-10 2000-04-10
US56040600A 2000-04-27 2000-04-27
US09/589,184 US6686447B1 (en) 1999-06-30 2000-06-05 Compositions and methods for the therapy and diagnosis of lung cancer
PCT/US2000/018061 WO2001000828A2 (en) 1999-06-30 2000-06-30 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (2)

Publication Number Publication Date
NO20016427D0 true NO20016427D0 (no) 2001-12-28
NO20016427L NO20016427L (no) 2002-02-25

Family

ID=27578819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016427A NO20016427L (no) 1999-06-30 2001-12-28 Blandinger og fremgangsmåter for behandling av diagnose av lungekreft

Country Status (15)

Country Link
US (1) US6630574B1 (no)
EP (1) EP1196565A2 (no)
JP (1) JP2004500029A (no)
CN (1) CN1367829A (no)
AR (1) AR032743A1 (no)
AU (1) AU769143B2 (no)
BR (1) BR0012069A (no)
CA (1) CA2380873A1 (no)
CZ (1) CZ20014718A3 (no)
HU (1) HUP0201757A3 (no)
MX (1) MXPA02000192A (no)
NO (1) NO20016427L (no)
NZ (1) NZ516381A (no)
PL (1) PL354093A1 (no)
WO (1) WO2001000828A2 (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084082A1 (en) * 1997-03-07 2006-04-20 Human Genome Sciences, Inc. 186 human secreted proteins
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) * 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001029088A1 (en) * 1999-10-19 2001-04-26 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
EP1230370A2 (en) * 1999-11-18 2002-08-14 Curagen Corporation Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
US7005499B1 (en) * 1999-11-18 2006-02-28 Genentech, Inc. Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
WO2001062921A2 (en) * 2000-02-22 2001-08-30 Lexicon Genetics Incorporated Novel human regulatory protein and polynucleotides encoding the same
KR100740761B1 (ko) * 2000-02-25 2007-07-19 옥스포드 글리코사이언시스(유케이) 리미티드 단백질
CA2408664A1 (en) * 2000-05-12 2001-11-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung F-box containing protein
CA2412211A1 (en) * 2000-06-23 2002-01-03 Genetech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AR031250A1 (es) * 2000-07-11 2003-09-17 Corixa Corp Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
AU2001287004A1 (en) * 2000-09-01 2002-03-13 Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services Xage-1, a gene expressed in multiple cancers, and uses thereof
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
AU2002311909A1 (en) * 2001-05-11 2002-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1270732A1 (en) * 2001-06-21 2003-01-02 Schuler, Gerold Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
AU2002356522A1 (en) * 2001-09-04 2003-04-07 Bristol-Myers Squibb Company Polynucleotide encoding adapter protein, pmn29
WO2003046165A1 (en) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
CA2508726A1 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
JP4643450B2 (ja) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス 癌高発現遺伝子
US7087733B2 (en) * 2003-09-02 2006-08-08 Ken-Shwo Dai Human ARL-related gene variants associated with cancers
US20120122103A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
KR101300544B1 (ko) 2004-03-31 2013-09-02 히로유키 아브라타니 항ｒｏｂｏ1항체를 이용하는 암의 진단 및 치료
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
NZ555571A (en) * 2004-12-06 2009-02-28 Sciclone Pharmaceuticals Inc Alpha thymosin peptides as cancer vaccine adjuvants
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8026084B2 (en) 2005-07-21 2011-09-27 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CN101283279A (zh) * 2005-07-29 2008-10-08 肿瘤疗法科学股份有限公司 以cdca1-kntc2复合物为靶标的筛选和nsclc治疗方法
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
JP5680304B2 (ja) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド 迅速な法医学的ｄｎａ分析法
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
BRPI0815578B8 (pt) 2007-08-20 2023-01-03 Oncotherapy Science Inc Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer)
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
WO2010033599A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010093943A1 (en) 2009-02-12 2010-08-19 Ibis Biosciences, Inc. Ionization probe assemblies
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc SYSTEMS FOR IDENTIFYING BIOLOGICAL SUBSTANCES
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
EP2488656B1 (en) 2009-10-15 2015-06-03 Ibis Biosciences, Inc. Multiple displacement amplification
NL2007536C2 (en) 2011-10-05 2013-04-08 Academisch Ziekenhuis Leiden Lumc Adjuvant compound.
CN104718284A (zh) * 2012-05-25 2015-06-17 塞勒克提斯公司 工程化用于免疫疗法的异体和免疫抑制耐受性t细胞的方法
CN103212077B (zh) * 2013-04-09 2015-09-23 梅林� Erbin抑制剂在制备抗肿瘤药物中的应用
JP6706208B2 (ja) * 2014-01-05 2020-06-03 バイオマーナ ホールディングス リミテッド Ｍｉｒｎａ比率を使用する肺がん決定
US20240279654A1 (en) * 2021-05-21 2024-08-22 Ionis Pharmaceuticals, Inc. Compounds for reducing ptbp1 expression

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246709A1 (en) * 1986-05-20 1987-11-25 Stichting Katholieke Universiteit Recombinant DNA and cDNA, mRNA, protein, antibodies, and a method of detecting tumor cells
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0897424A1 (en) * 1996-03-15 1999-02-24 Sagami Chemical Research Center Human membrane antigen tm4 superfamily protein and dna encoding this protein
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
AU5923398A (en) * 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
US6146877A (en) * 1997-03-21 2000-11-14 The Trustees Of Columbia University In The City Of New York Identification of the progression elevated gene-3 and uses thereof
CA2306777A1 (en) 1997-10-22 1999-04-29 Helix Research Institute Method for screening full-length cdna clones
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
US20020102604A1 (en) 1999-12-08 2002-08-01 Milne Edwards Jean-Baptiste Dumas Full-length human cDNAs encoding potentially secreted proteins
WO2000022130A2 (en) 1998-10-15 2000-04-20 Chiron Corporation Metastatic breast and colon cancer regulated genes
WO2000021990A1 (en) 1998-10-15 2000-04-20 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2000055375A1 (en) 1999-03-17 2000-09-21 Alphagene, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
CA2380873A1 (en) 2001-01-04
MXPA02000192A (es) 2004-08-12
US6630574B1 (en) 2003-10-07
BR0012069A (pt) 2002-08-27
CN1367829A (zh) 2002-09-04
NZ516381A (en) 2004-03-26
HUP0201757A2 (en) 2002-09-28
CZ20014718A3 (cs) 2003-01-15
AR032743A1 (es) 2003-11-26
HUP0201757A3 (en) 2010-01-28
AU769143B2 (en) 2004-01-15
WO2001000828A2 (en) 2001-01-04
AU5902700A (en) 2001-01-31
EP1196565A2 (en) 2002-04-17
JP2004500029A (ja) 2004-01-08
PL354093A1 (en) 2003-12-29
NO20016427L (no) 2002-02-25
WO2001000828A3 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO20003853D0 (no) Forbindelser for terapi og diagnose av lungekreft og metoder for deres anvendelse
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
NO20030714D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20013002L (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
EP1571968A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
EP1589933A4 (en) COMPOSITIONS AND METHODS FOR DIETUMOR DIAGNOSIS AND TREATMENT
EP1581119A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE
EP1572091A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
EP1578996A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
EP1553912A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
EP1516049A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF LUNG CANCER
EP1575571A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1446013A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
NO20014804L (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
NO20025594D0 (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application